JP2019501927A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501927A5 JP2019501927A5 JP2018536252A JP2018536252A JP2019501927A5 JP 2019501927 A5 JP2019501927 A5 JP 2019501927A5 JP 2018536252 A JP2018536252 A JP 2018536252A JP 2018536252 A JP2018536252 A JP 2018536252A JP 2019501927 A5 JP2019501927 A5 JP 2019501927A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrate
- pharmaceutically acceptable
- acceptable salt
- cycloalkyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 claims 4
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 4
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 4
- 201000002215 juvenile rheumatoid arthritis Diseases 0.000 claims 4
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 2
- 208000003950 B-cell lymphoma Diseases 0.000 claims 2
- 206010012434 Dermatitis allergic Diseases 0.000 claims 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000005777 Lupus Nephritis Diseases 0.000 claims 2
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 2
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims 2
- 206010039710 Scleroderma Diseases 0.000 claims 2
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 2
- 206010046851 Uveitis Diseases 0.000 claims 2
- 206010047115 Vasculitis Diseases 0.000 claims 2
- 201000010105 allergic rhinitis Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 208000019069 chronic childhood arthritis Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000024908 graft versus host disease Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662278085P | 2016-01-13 | 2016-01-13 | |
| US62/278,085 | 2016-01-13 | ||
| PCT/US2017/013100 WO2017123695A1 (en) | 2016-01-13 | 2017-01-12 | Isoquinolones as btk inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501927A JP2019501927A (ja) | 2019-01-24 |
| JP2019501927A5 true JP2019501927A5 (enExample) | 2020-02-13 |
| JP6916185B2 JP6916185B2 (ja) | 2021-08-11 |
Family
ID=57907002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018536252A Active JP6916185B2 (ja) | 2016-01-13 | 2017-01-12 | Btk阻害剤としてのイソキノロン類 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10570118B2 (enExample) |
| EP (1) | EP3402789B1 (enExample) |
| JP (1) | JP6916185B2 (enExample) |
| WO (1) | WO2017123695A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017163078A1 (en) * | 2016-03-24 | 2017-09-28 | Mission Therapeutics Limited | 1-cyano-pyrrolidine derivatives as dbu inhibitors |
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| WO2020234103A1 (en) * | 2019-05-21 | 2020-11-26 | Bayer Aktiengesellschaft | Identification and use of kras inhibitors |
| PL3972603T3 (pl) * | 2019-05-23 | 2025-02-03 | Novartis Ag | Sposoby leczenia zespołu sjögrena przy użyciu inhibitora kinazy tyrozynowej brutona |
| EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| US20240100172A1 (en) | 2020-12-21 | 2024-03-28 | Hangzhou Jijing Pharmaceutical Technology Limited | Methods and compounds for targeted autophagy |
| CN115650851A (zh) * | 2022-11-10 | 2023-01-31 | 无锡双启科技有限公司 | 一种2-氟-4-溴-6-甲基苯甲酸甲酯的制备方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9608435D0 (en) | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
| EA007933B1 (ru) | 2001-08-13 | 2007-02-27 | Янссен Фармацевтика Н.В. | 2,4,5-тризамещенные производные тиазолила и их противовоспалительная активность |
| WO2003072541A2 (en) | 2001-09-27 | 2003-09-04 | Smithkline Beecham Corporation | Chemical compounds |
| FR2881426B1 (fr) | 2005-02-03 | 2007-03-30 | Aventis Pharma Sa | Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation |
| EP2007732B1 (en) | 2006-04-11 | 2011-11-23 | Vertex Pharmaceuticals, Inc. | Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
| HUE028086T2 (en) | 2006-09-22 | 2016-11-28 | Pharmacyclics Llc | Inhibitors of bruton's tyrosine kinase |
| EP2548558A1 (en) | 2007-03-28 | 2013-01-23 | Pharmacyclics, Inc. | Nitrogen-containing condensed heterocyclic as inhibitors of bruton's tyrosine kinase |
| CA2710462C (en) * | 2008-02-05 | 2015-11-24 | F. Hoffmann-La Roche Ag | Pyridinones and pyridazinones |
| CN103408533B (zh) * | 2008-06-24 | 2015-08-26 | 霍夫曼-拉罗奇有限公司 | 新型取代的吡啶-2-酮和哒嗪-3-酮 |
| ES2445099T3 (es) | 2008-07-29 | 2014-02-28 | Université de Liège | Una prueba de marcador genético para braquispina y fertilidad en ganado vacuno |
| GB0820819D0 (en) | 2008-11-13 | 2008-12-24 | Sareum Ltd | Pharmaceutical compounds |
| JP2012516329A (ja) | 2009-01-30 | 2012-07-19 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | Pi3k阻害剤としてのヘテロアリールおよびその使用 |
| US8299077B2 (en) * | 2009-03-02 | 2012-10-30 | Roche Palo Alto Llc | Inhibitors of Bruton's tyrosine kinase |
| CA2784647A1 (en) | 2009-12-17 | 2011-07-14 | Merck Patent Gmbh | Inhibitors of sphingosine kinase |
| CN102918040B (zh) | 2010-05-31 | 2015-03-18 | 小野药品工业株式会社 | 6-羟基嘌呤衍生物 |
| EP2603216A4 (en) | 2010-08-11 | 2013-12-18 | Millennium Pharm Inc | HETEROARYLE AND USES THEREOF |
| SG194728A1 (en) | 2011-05-17 | 2013-12-30 | Hoffmann La Roche | Inhibitors of bruton's tyrosine kinase |
| US8377946B1 (en) | 2011-12-30 | 2013-02-19 | Pharmacyclics, Inc. | Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
| CN104080789B (zh) | 2012-01-31 | 2016-05-11 | 南京奥昭生物科技有限公司 | 作为布鲁顿酪氨酸激酶抑制剂的环状分子 |
| WO2013157022A1 (en) * | 2012-04-20 | 2013-10-24 | Advinus Therapeutics Limited | Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof |
| US20140045813A1 (en) | 2012-08-10 | 2014-02-13 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as btk inhibitors |
| CA2881761A1 (en) * | 2012-09-13 | 2014-03-20 | Christine E. Brotherton-Pleiss | Inhibitors of bruton's tyrosine kinase |
| CN105008344B (zh) | 2012-11-02 | 2017-07-25 | 辉瑞公司 | 布鲁顿氏酪氨酸激酶抑制剂 |
| CN103848810A (zh) | 2012-11-30 | 2014-06-11 | 北京赛林泰医药技术有限公司 | 鲁顿酪氨酸激酶抑制剂 |
| RU2016112314A (ru) * | 2013-09-03 | 2017-10-05 | Карна Байосайенсиз, Инк. | Новое 2,6-диаминопиримидиновое производное |
| WO2015050703A1 (en) * | 2013-10-04 | 2015-04-09 | Yi Chen | Inhibitors of bruton's tyrosine kinase |
| WO2015116485A1 (en) | 2014-01-29 | 2015-08-06 | Boehringer Ingelheim International Gmbh | Pyrazole compounds as btk inhibitors |
| PE20181074A1 (es) | 2015-12-16 | 2018-07-04 | Boehringer Ingelheim Int | Compuestos heteroaromaticos como inhibidores de btk |
-
2017
- 2017-01-12 JP JP2018536252A patent/JP6916185B2/ja active Active
- 2017-01-12 WO PCT/US2017/013100 patent/WO2017123695A1/en not_active Ceased
- 2017-01-12 US US16/069,046 patent/US10570118B2/en active Active
- 2017-01-12 EP EP17701778.7A patent/EP3402789B1/en active Active